393 related articles for article (PubMed ID: 4886667)
21. Effects of drugs on the 6-hydroxydopamine induced degeneration of adrenergic nerves.
Jonsson G; Malmfors T; Sachs C
Res Commun Chem Pathol Pharmacol; 1972 May; 3(3):543-56. PubMed ID: 5034513
[No Abstract] [Full Text] [Related]
22. Steric aspects of adrenergic drugs. I. Comparative effects of DL isomers and desoxy derivatives.
Patil PN; LaPidus JB; Tye A
J Pharmacol Exp Ther; 1967 Jan; 155(1):1-12. PubMed ID: 5334677
[No Abstract] [Full Text] [Related]
23. Restoration of the chronotropic effect of tyramine on rat atria after reserpine.
Murnaghan MF
Br J Pharmacol; 1968 Sep; 34(1):88-98. PubMed ID: 4877602
[TBL] [Abstract][Full Text] [Related]
24. Cardiovascular complications of antidepressant therapy. Interactions at the adrenergic neuron.
Raisfeld IH
Am Heart J; 1972 Jan; 83(1):129-33. PubMed ID: 4551683
[No Abstract] [Full Text] [Related]
25. The human platelet as a pharmacologic model for the adrenergic neuron. The uptake and release of norepinephrine.
Abrams WB; Solomon HM
Clin Pharmacol Ther; 1969; 10(5):702-9. PubMed ID: 4390109
[No Abstract] [Full Text] [Related]
26. Steric aspects of adrenergic drugs. XIV. Actions and interactions of "indirectly" acting L(+)-isomers and desoxy derivatives of sympathomimetic amines.
Patil PN; Patel DG; Tye A
Arch Int Pharmacodyn Ther; 1969 Nov; 182(1):32-43. PubMed ID: 5391836
[No Abstract] [Full Text] [Related]
27. Effect of various procedures on the repletion of cardiac catecholamine stores after tyramine.
Bhagat B; Gilliam J
J Pharmacol Exp Ther; 1965 Oct; 150(1):41-5. PubMed ID: 4379155
[No Abstract] [Full Text] [Related]
28. Effect of antidepressant and adrenergic blocking drugs on hyperthermia induced by reserpine.
Jori A; Paglialunga S; Garattini S
Arch Int Pharmacodyn Ther; 1967 Feb; 165(2):384-93. PubMed ID: 4382965
[No Abstract] [Full Text] [Related]
29. False neurochemical transmitters and response to tyramine in reserpine pretreated preparations.
Bhagat B; Jackson C; Wong HY; Shein K; Bovell G
Life Sci; 1965 Jul; 4(13):1281-7. PubMed ID: 5321616
[No Abstract] [Full Text] [Related]
30. RECENT VIEWS ON MECHANISMS FOR LOWERING SYMPATHETIC TONE.
BRODIE BB
Circulation; 1963 Nov; 28():970-86. PubMed ID: 14085298
[No Abstract] [Full Text] [Related]
31. Effect of alpha-methyltyrosine on stress-induced changes in seizure susceptibility.
Goldberg ME; Salama AI
Eur J Pharmacol; 1970 Feb; 9(2):175-82. PubMed ID: 5437153
[No Abstract] [Full Text] [Related]
32. Studies in vitro of amine uptake mechanisms in heart.
Giachetti A; Shore PA
Biochem Pharmacol; 1966 May; 15(5):607-14. PubMed ID: 5336260
[No Abstract] [Full Text] [Related]
33. [Adrenergic mechanisms of antidepressant action].
Mashkovskiĭ MD
Zh Nevropatol Psikhiatr Im S S Korsakova; 1970 May; 70(5):750-9. PubMed ID: 4916171
[No Abstract] [Full Text] [Related]
34. The effects of guanethidine, bretylium and debrisoquine on the accumulation of noradrenaline in constricted postganglionic sympathetic nerves in vitro.
Tomlinson DR; Mayor D
Eur J Pharmacol; 1973 Feb; 21(2):161-70. PubMed ID: 4696099
[No Abstract] [Full Text] [Related]
35. Structural activity relationships of a series of amines injected before and after monoamine oxidase inhibitor.
Gatgounis J
Arch Int Pharmacodyn Ther; 1965 Apr; 154(2):412-20. PubMed ID: 5838346
[No Abstract] [Full Text] [Related]
36. The role of monoamine oxidase in the intraneuronal metabolism of norepinephrine released by indirectly-acting sympathomimetic amines or by adrenergic nerve stimulation.
Smith CB
J Pharmacol Exp Ther; 1966 Feb; 151(2):207-20. PubMed ID: 5932599
[No Abstract] [Full Text] [Related]
37. The influence of sympathomimetic amines, monoamine oxidase inhibitors, and antihypertensives upon the energy metabolism in the rat heart.
Hilliard WG; Oliver WT; Van Petten GR
Can J Physiol Pharmacol; 1966 Jul; 44(4):605-13. PubMed ID: 5968213
[No Abstract] [Full Text] [Related]
38. Affective disorders and norepinephrine pharmacology.
Schildkraut JJ; Schanberg SM; Kopin IJ; Durell J
Int Psychiatry Clin; 1969; 6(2):83-141. PubMed ID: 4897536
[No Abstract] [Full Text] [Related]
39. 4,4,6-trimethyl-3,4-dihydropyrimidine-2-thiol, an effective inhibitor of dopamine-beta-hydroxylation in vivo.
Porter CC; Torchiana ML
Biochem Pharmacol; 1971 Jan; 20(1):183-91. PubMed ID: 4398314
[No Abstract] [Full Text] [Related]
40. Further evidence for a sodium-dependent, optically specific and reserpine-sensitive amine carrier mechanism at the adrenergic neuron.
Sugrue MF; Shore PA
J Pharmacol Exp Ther; 1971 May; 177(2):389-97. PubMed ID: 5568795
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
